ATLANTA--(BUSINESS WIRE)--MIV Therapeutics Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, has released a commissioned whitepaper to delve into the potential risks and strategic opportunities in the ever-evolving stent industry in the U.S. and abroad in some of the world’s fastest-growing economies.
